Full text is available at the source.
A novel anti-acute lung injury mechanism of astilbin: inhibition of epithelial cells ferroptosis by targeting NRF2 activation via binding Val608 site of NRF2
Astilbin may reduce acute lung injury by preventing lung cell death through activating NRF2 at the Val608 site
AI simplified
Abstract
Astilbin (ATB) significantly alleviated acute lung injury in a mouse model.
- ATB decreased inflammation caused by lipopolysaccharide (LPS) in acute lung injury.
- The compound inhibited ferroptosis in epithelial cells by increasing the expression of GPX4 and xCT.
- ATB promoted the movement of NRF2 into the nucleus in LPS-treated cells.
- Inhibition of NRF2 reversed the protective effects of ATB on ferroptosis and inflammation.
- NRF2 knockout in mice eliminated the protective effects of ATB against acute lung injury.
- ATB binds to the Val608 amino acid of NRF2, enhancing its activity.
AI simplified